Gabriel Baltazar-Martins

Dr. Gabriel Baltazar-Martins

University Camilo José Cela
orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Gabriel Baltazar-MartinsGabriel Baltazar-Martins
Gabriel Baltazar-Martins
DSDiego Brito de Souza
Diego Brito de Souza
Millán Aguilar-NavarroMillán Aguilar-Navarro
Millán Aguilar-Navarro
JMJesús Muñoz-Guerra
Jesús Muñoz-Guerra
MPMaría del Mar Plata
María del Mar Plata
Juan Del CosoJuan Del Coso
Juan Del Coso
Dietary supplementation is a common strategy to achieve a specific health status or performance benefit. Several investigations have focused on the prevalence of dietary supplement use by athletes. However, information on how athletes manage the use and purchase of dietary supplements is scarce. Five hundred and twenty-seven high-performance athletes (346 males and 181 females), participating in individual and team sports, completed a validated questionnaire about use and purchase patterns of dietary supplements. The dietary supplements were categorized according to the International Olympic Committee (IOC) consensus. Sixty four percent of the athletes (n = 337) used dietary supplements (median = 3; range 1 to 12). Age, sex, type of sport, level of competition, and professionalism influenced the prevalence of dietary supplement use (all p < 0.05). The most prevalent dietary supplement consumed was proteins (41%; n = 137), followed by amino acids/BCAA-based supplements (37%; n = 124). Additionally, as per group of supplements according to IOC consensus, 18% of the supplements were rated as having a low level of scientific evidence (e.g., glutamine, HMB, L-carnitine, etc). Most athletes (45%, n = 152) purchased dietary supplements in a store and 24% (n = 81) obtained them from a sponsor. Most athletes also (42%, n = 141) reported a self-organization of supplementation and did not consult with any professional. Last, 81% (n = 273) of athletes consuming supplements did not know any platform to check supplement safety/quality. For those who do not use dietary supplements (36% of the total sample, n = 190), most reported that they do not consider supplements necessary (72%, n = 137). Dietary supplementation appears to be widely used in sport with a considerable proportion of athletes consuming supplements with low level of scientific evidence. Additionally, athletes seem to rely on inadequate sources of information and may be largely unaware of sources to detect supplement contamination.

15 July 2019 in Nutrients
Verified
Journal Article
Open access
PDF file
Juan José SalineroJuan José Salinero
Juan José Salinero
BLBeatriz Lara
Beatriz Lara
EJEster Jiménez-Ormeño
Ester Jiménez-Ormeño
BRBlanca Romero-Moraleda
Blanca Romero-Moraleda
VGVerónica Giráldez-Costas
Verónica Giráldez-Costas
Juan Del CosoJuan Del Coso
Juan Del Coso

13 July 2020 in Sports
Verified
Journal Article
Open access
PDF file
Gabriel Baltazar-MartinsGabriel Baltazar-Martins
Gabriel Baltazar-Martins
Jorge Gutiérrez-HellínJorge Gutiérrez-Hellín
Jorge Gutiérrez-Hellín
Millán Aguilar-NavarroMillán Aguilar-Navarro
Millán Aguilar-Navarro
CRCarlos Ruiz-Moreno
Carlos Ruiz-Moreno
Victor Moreno-PérezVictor Moreno-Pérez
Victor Moreno-Pérez
Juan Del CosoJuan Del Coso
Juan Del Coso
Genetic factors play a significant role in athletic performance and its related phenotypes such as power, strength and aerobic capacity. In this regard, the lack of a muscle protein due to a genetic polymorphism has been found to affect sport performance in a wide variety of ways. α-actinin-3 is a protein located within the skeletal muscle with a key role in the production of sarcomeric force. A common stop-codon polymorphism (rs1815739; R577X) in the gene that codes for α-actinin-3 (ACTN3) produces individuals with the XX genotype that lack expression of a functional α-actinin-3. In contrast, individuals with the R-allele (i.e., RX vs. RR genotypes) in this polymorphism can express α-actinin-3. Interestingly, around ~18% of the world population have the XX genotype and much has been debated about why a polymorphism that produces a lack of a muscle protein has endured natural selection. Several investigations have found that α-actinin-3 deficiency due to XX homozygosity in the ACTN3 R577X polymorphism can negatively affect sports performance through several structural, metabolic, or signaling changes. In addition, new evidence suggests that α-actinin-3 deficiency may also impact sports performance through indirect factors such a higher risk for injury or lower resistance to muscle-damaging exercise. The purpose of this discussion is to provide a clear explanation of the effect of α-actinin-3 deficiency due to the ACTN3 XX genotype on sport. Key focus has been provided about the effect of α-actinin-3 deficiency on morphologic changes in skeletal muscle, on the low frequency of XX athletes in some athletic disciplines, and on injury epidemiology.

29 May 2019 in Genes
Verified
Journal Article
Open access
PDF file
Juan Del CosoJuan Del Coso
Juan Del Coso
Victor Moreno-PérezVictor Moreno-Pérez
Victor Moreno-Pérez
Jorge Gutiérrez-HellínJorge Gutiérrez-Hellín
Jorge Gutiérrez-Hellín
Gabriel Baltazar-MartinsGabriel Baltazar-Martins
Gabriel Baltazar-Martins
CRCarlos Ruiz-Moreno
Carlos Ruiz-Moreno
Alejandro LuciaAlejandro Lucia
Alejandro Lucia
Background: Homozygosity for the X-allele in the ACTN3 R577X (rs1815739) polymorphism results in the complete absence of α-actinin-3 in sarcomeres of fast-type muscle fibers. In elite athletes, the ACTN3 XX genotype has been related to inferior performance in speed and power-oriented sports; however, its influence on exercise phenotypes in recreational athletes has received less attention. We sought to determine the influence of ACTN3 genotypes on common exercise phenotypes in recreational marathon runners. Methods: A total of 136 marathoners (116 men and 20 women) were subjected to laboratory testing that included measurements of body composition, isometric muscle force, muscle flexibility, ankle dorsiflexion, and the energy cost of running. ACTN3 genotyping was performed using TaqMan probes. Results: 37 runners (27.2%) had the RR genotype, 67 (49.3%) were RX and 32 (23.5%) were XX. There was a difference in body fat percentage between RR and XX genotype groups (15.7 ± 5.8 vs. 18.8 ± 5.5%; effect size, ES, = 0.5 ± 0.4, p = 0.024), whereas the distance obtained in the sit-and-reach-test was likely lower in the RX than in the XX group (15.3 ± 7.8 vs. 18.4 ± 9.9 cm; ES = 0.4 ± 0.4, p = 0.046). Maximal dorsiflexion during the weight-bearing lunge test was different in the RR and XX groups (54.8 ± 5.8 vs. 57.7 ± 5.1 degree; ES = 0.5 ± 0.5, p = 0.044). Maximal isometric force was higher in the RR than in the XX group (16.7 ± 4.7 vs. 14.7 ± 4.0 N/kg; ES = −0.5 ± 0.3, p = 0.038). There was no difference in the energy cost of running between genotypes (~4.8 J/kg/min for all three groups, ES ~0.2 ± 0.4). Conclusions: The ACTN3 genotype might influence several exercise phenotypes in recreational marathoners. Deficiency in α-actinin-3 might be accompanied by higher body fatness, lower muscle strength and higher muscle flexibility and range of motion. Although there is not yet a scientific rationale for the use of commercial genetic tests to predict sports performance, recreational marathon runners who have performed such types of testing and have the ACTN3 XX genotype might perhaps benefit from personalized strength training to improve their performance more than their counterparts with other ACTN3 genotypes.

8 January 2021 in Genes
Verified
Journal Article
Open access
PDF file
Jorge Gutiérrez-HellínJorge Gutiérrez-Hellín
Jorge Gutiérrez-Hellín
Gabriel Baltazar-MartinsGabriel Baltazar-Martins
Gabriel Baltazar-Martins
Millán Aguilar-NavarroMillán Aguilar-Navarro
Millán Aguilar-Navarro
CRCarlos Ruiz-Moreno
Carlos Ruiz-Moreno
JMJesús Oliván Mallén
Jesús Oliván Mallén
Juan Del CosoJuan Del Coso
Juan Del Coso
The p.R577X polymorphism (rs1815739) in the ACTN3 gene causes individuals with the ACTN3 XX genotype to be deficient in functional α-actinin-3. Previous investigations have found that XX athletes are more prone to suffer non-contact muscle injuries. This investigation aimed to determine the influence of the ACTN3 R577X polymorphism in the injury epidemiology of elite endurance athletes. Using a cross-sectional experiment, the epidemiology of running-related injuries was recorded for one season in a group of 89 Spanish elite endurance runners. ACTN3 R577X genotype was obtained for each athlete using genomic DNA samples. From the study sample, 42.7% of athletes had the RR genotype, 39.3% had the RX genotype, and 18.0% had the XX genotype. A total of 96 injuries were recorded in 57 athletes. Injury incidence was higher in RR runners (3.2 injuries/1000 h of running) than in RX (2.0 injuries/1000 h) and XX (2.2 injuries/1000 h; p = 0.030) runners. RR runners had a higher proportion of injuries located in the Achilles tendon, RX runners had a higher proportion of injuries located in the knee, and XX runners had a higher proportion of injuries located in the groin (p = 0.025). The ACTN3 genotype did not affect the mode of onset, the severity, or the type of injury. The ACTN3 genotype slightly affected the injury epidemiology of elite endurance athletes with a higher injury rate in RR athletes and differences in injury location. However, elite ACTN3 XX endurance runners were not more prone to muscle-type injuries.

5 July 2019 in British Journal of Sports Medicine
Verified
Journal Article
Closed access
PDF file
Gabriel Baltazar-MartinsGabriel Baltazar-Martins
Gabriel Baltazar-Martins
DSDiego Brito de Souza
Diego Brito de Souza
Millán Aguilar-NavarroMillán Aguilar-Navarro
Millán Aguilar-Navarro
JGJozo Grgic
Jozo Grgic
Juan Del CosoJuan Del Coso
Juan Del Coso